SCHEMBL4036739

SCHEMBL4036739

COc1ccc(OC)c(Nc2nc(N)nn2-c2ccc(C#N)cc2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 3/20 0.51
GAA P10253 5/20 0.43
LMNA P02545 3/20 0.43
HPGD P15428 2/20 0.43
KLF5 Q13887 1/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
MAPT P10636 6/20 0.42
KMT2A Q03164 4/20 0.42
TSHR P16473 3/20 0.42
TP53 P04637 2/20 0.42
ALOX15 P16050 1/20 0.42
MAPK1 P28482 1/20 0.42
HTT P42858 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
HSD17B10 Q99714 1/20 0.42
MEN1 O00255 3/20 0.41
USP2 O75604 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
DHFR P00374 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4047573 0.83 FLT3 (0.70) FLT3GAALMNANPC1RAB9A
SCHEMBL4037629 0.81 FLT3 (0.55) FLT3HPGDKMT2AHTTHSD17B10
SCHEMBL2088439 0.74 FLT3 (0.67) FLT3GAANPC1RAB9AMAPT
SCHEMBL4040262 0.73 FLT3 (0.51) FLT3HPGDKMT2ATSHRNPSR1
SCHEMBL4041596 0.72 FLT3 (0.64) FLT3GAALMNANPC1RAB9A
SCHEMBL4038395 0.70 FLT3 (0.44) FLT3BRAF
SCHEMBL2088943 0.67 FLT3 (1.00) FLT3MAPTTSHRAURKAKIT
SCHEMBL2453918 0.67 NPC1 (0.76) GAALMNAHPGDNPC1RAB9A
SCHEMBL4042662 0.67 FLT3 (0.72) FLT3KMT2AMEN1MAPKAPK2AURKA
SCHEMBL4036447 0.66 FLT3 (0.72) FLT3GAANPC1RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1562589-B1 DIAMINOTRIAZOLES USEFUL AS INHIBITORS OF PROTEIN KINASES VERTEX PHARMA (US) 2009-01-07 EP disclosed
CN-1738615-A Diaminotriazoles as inhibitors of protein kinases VERTEX PHARMA (US) 2006-02-22 CN disclosed